Suppliers and packagers for CORTIFOAM

CORTIFOAM

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant	Tradename	Generic Name	Dosage	NDA	NDA/ANDA	Supplier	Package Code	Package	Marketing Start
Viatris	CORTIFOAM	hydrocortisone acetate	AEROSOL, METERED;RECTAL	017351	NDA	Viatris Specialty LLC	0037-6830-15	1 CANISTER in 1 CARTON (0037-6830-15) / 15 g in 1 CANISTER	2015-06-15

Suppliers for the Pharmaceutical Drug: CORTIFOAM

Last updated: July 30, 2025

Introduction

CORTIFOAM is a depot corticosteroid formulation primarily used in veterinary medicine to treat allergic dermatitis and inflammation in animals. Its active ingredient, triamcinolone acetonide, is a potent synthetic corticosteroid. As a specialized veterinary pharmaceutical, the supply chain for CORTIFOAM involves various manufacturers and distributors who operate under stringent regulatory frameworks to ensure quality, safety, and efficacy. This article provides a comprehensive overview of key suppliers involved in the production, distribution, and supply of CORTIFOAM, outlining the landscape of global and regional sources.

Understanding CORTIFOAM and Market Dynamics

CORTIFOAM is predominantly manufactured by leading pharmaceutical companies with expertise in corticosteroid formulations. The drug’s market is niche, primarily targeting veterinary practitioners worldwide, especially in regions where veterinary health infrastructure supports the administration of injectable corticosteroids. The complex supply chain includes raw material suppliers, formulators, and distributors, with regional differences influencing availability and pricing.

Major Manufacturers of CORTIFOAM and Active Ingredient

1. Bayer AG

Bayer remains a prominent provider in the veterinary pharmaceutical space, including corticosteroid products like CORTIFOAM. The company’s manufacturing facilities adhere to global Good Manufacturing Practices (GMP), ensuring high-quality standards. Bayer's products are widely distributed across North America, Europe, and Asia, making it a significant supplier for veterinary clinics and pharmacies.

2. Zoetis Inc.

As one of the leading global animal health companies, Zoetis offers corticosteroid formulations, including products similar to CORTIFOAM, although they may market under different trade names. Their focus on supply chain resilience and regulatory compliance makes them a key player in the veterinary corticosteroid market.

3. Virbac S.A.

Virbac specializes in veterinary pharmaceuticals and has manufacturing capabilities for corticosteroid injections. Though not always directly selling CORTIFOAM, they are an important regional supplier of corticosteroid products, often sourcing active ingredients from global manufacturers.

4. Eli Lilly and Company

Lilly's veterinary division produces corticosteroids used in animal health. Their active pharmaceutical ingredient (API) manufacturing units supply raw materials for products akin to CORTIFOAM, particularly in North America and Europe.

Raw Material Suppliers for Triamcinolone Acetonide

The production of CORTIFOAM hinges on the supply of high-purity triamcinolone acetonide. Key raw material suppliers include:

• LG Chem (South Korea) — a global leader in specialty chemicals, providing pharmaceutical-grade corticosteroids. LG Chem’s API manufacturing plants are certified under GMP standards, ensuring consistent quality.
• Hovione (Portugal) — supplies pharmaceutical solvents and intermediates used in corticosteroid synthesis, supporting API production.
• Sinochem (China) — a major chemical conglomerate with capacities for steroid intermediate synthesis and API manufacturing, serving both domestic and international markets.

Regional Distributors and Wholesale Suppliers

Distribution channels are crucial for ensuring the availability of CORTIFOAM in veterinary clinics. Notable regional distributors include:

• Vetoquinol — operates across Europe and North America, distributing veterinary pharmaceuticals, including corticosteroids.
• Dechra Pharmaceuticals — a UK-based company with a broad veterinary product portfolio, including corticosteroid injections.
• MediTech — regional distributor across Asia, sourcing CORTIFOAM from global suppliers and ensuring regional compliance.

Regulatory and Certification Considerations

Suppliers must comply with local regulatory agencies such as the U.S. Food and Drug Administration (FDA), European Medicines Agency (EMA), and other national agencies. For instance, the importation and distribution of CORTIFOAM require GMP certification and adherence to veterinary drug standards.

Challenges in Supply Chain

• Regulatory hurdles: Variability in approvals across regions can delay or restrict supply.
• Raw material quality: Ensuring consistent quality of triamcinolone acetonide remains essential, especially given the complexity of steroid synthesis.
• Global logistics: Supply chain disruptions, such as those caused by geopolitical tensions or pandemics, impact availability.

Emerging Trends and Future Outlook

The veterinary pharmaceutical sector is experiencing increased demand due to rising animal healthcare awareness. Suppliers are investing in advanced manufacturing techniques and establishing regional hubs to reduce dependency on single sources. Additionally, biosimilar corticosteroids and alternative formulations are emerging, potentially diversifying supply options.

Conclusion

The supply of CORTIFOAM involves a complex network of global manufacturers, raw material suppliers, and regional distributors. Major pharmaceutical companies such as Bayer, Zoetis, and Virbac form the backbone of the market, sourcing raw materials from key chemical suppliers like LG Chem and Sinochem. Ensuring quality, regulatory compliance, and logistical resilience remains paramount for uninterrupted supply. Future developments in manufacturing and supply chain diversification will likely enhance availability and reduce costs, supporting the sustained use of CORTIFOAM in veterinary therapeutics.

Key Takeaways

• Major suppliers include Bayer AG, Zoetis, and Virbac, supported by raw material providers like LG Chem and Sinochem.
• The supply chain for CORTIFOAM relies heavily on GMP-certified manufacturing and regional distribution networks.
• Regulatory compliance and quality control are critical for the global distribution of corticosteroid products.
• Supply chain disruptions pose risks but are mitigated by regional manufacturing hubs and diversification strategies.
• Evolving veterinary healthcare demands will shape future supplier landscapes, emphasizing innovation and resilience.

FAQs

1. Who are the primary manufacturers of CORTIFOAM?
   Bayer AG and Zoetis are among the leading manufacturers involved in producing CORTIFOAM or similar veterinary corticosteroid formulations.

2. Where does the active ingredient triamcinolone acetonide originate?
   Major raw material suppliers include LG Chem (South Korea), Sinochem (China), and Hovione (Portugal), providing pharmaceutical-grade corticosteroid intermediates.

3. How do regional regulations impact CORTIFOAM supply?
   Local regulatory requirements for GMP, import approvals, and veterinary drug standards can delay or restrict distribution, necessitating compliance and certification by suppliers.

4. What challenges threaten the continuous supply of CORTIFOAM?
   Challenges include raw material shortages, regulatory delays, geopolitical issues, and logistical disruptions, which can impact manufacturing and delivery timelines.

5. Are biosimilars affecting the supply chain of corticosteroid products like CORTIFOAM?
   Yes, emerging biosimilars and alternative corticosteroid formulations could diversify supply options, potentially impacting traditional suppliers and market dynamics.

Sources

1. [1] Bayer AG Veterinary Division. Official Website.
2. [2] Zoetis Global Corporate Data. Animal Health Product Portfolio.
3. [3] Virbac Annual Report 2022. Product Line and Manufacturing Capabilities.
4. [4] LG Chem. Pharmaceutical Intermediates & APIs.
5. [5] Sinochem Group. Chemical and API Production Capacity Reports.